Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis - Authors' reply

被引：0

作者：

Guttman-Yassky, Emma ^{[1
,2
]}

Simpson, Eric L. ^{[3
]}

Reich, Kristian ^{[4
]}

Kabashima, Kenji ^{[5
]}

Igawa, Ken ^{[6
]}

Suzuki, Tetsuya ^{[7
]}

Mano, Hirotaka ^{[7
]}

Matsui, Takeshi ^{[7
]}

Esfandiari, Ehsanollah ^{[8
]}

Furue, Masutaka ^{[9
]}

机构：

[1] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA

[2] Icahn Sch Med Mt Sinai, Dept Allergy & Immunol, New York, NY 10029 USA

[3] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR USA

[4] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Translat Res Inflammatory Skin Dis, Hamburg, Germany

[5] Kyoto Univ, Dept Dermatol, Kyoto, Japan

[6] Dokkyo Med Univ, Dept Dermatol, Tochigi, Japan

[7] Kyowa Kirin, Tokyo, Japan

[8] Kyowa Kirin Int, London, England

[9] Kyushu Univ, Dept Dermatol, Fukuoka, Japan

来源：

LANCET | 2023年 / 402卷 / 10415期

关键词：

D O I：

10.1016/S0140-6736(23)01618-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1834 / 1834

页数：1

共 50 条

[1] Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis
Devjani, Shivali
Engel, Priya, V
Javadi, Sogol S.
Smith, Brandon
Wu, Jashin J.
LANCET, 2023, 402 (10415): : 1833 - 1834
[2] ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis
Guttman-Yassky, Emma
Simpson, Eric
Bissonnette, Robert
Eichenfield, Lawrence F.
Kabashima, Kenji
Luna, Paula C.
Hercogova, Jana Tresnak
Spelman, Lynda
Worm, Margitta
Esfandiari, Ehsanollah
Arai, Takahiro
Mano, Hirotaka
Charuworn, Prista
Wang, Andrea
Kricorian, Gregory
IMMUNOTHERAPY, 2025, 17 (02) : 83 - 94
[3] Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
Smith, Brandon I.
Engel, Priya
Wu, Jashin
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (24): : 2299 - 2300
[4] Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis
Nettis, Eustachio
Patella, Vincenzo
Lombardo, Carla
Detoraki, Aikaterini
Macchia, Luigi
Di Leo, Elisabetta
Carbonara, Monica
Canonica, Giorgio W.
Bonzano, Laura
ALLERGY, 2020, 75 (10) : 2653 - 2661
[5] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
Zheng, Y.
BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 72 - 72
[6] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
Khattri, Saakshi
Brunner, Patrick M.
Garcet, Sandra
Finney, Robert
Cohen, Steven R.
Oliva, Margeaux
Dutt, Riana
Fuentes-Duculan, Judilyn
Zheng, Xiuzhong
Li, Xuan
Bonifacio, Kathleen M.
Kunjravia, Norma
Coats, Israel
Cueto, Inna
Gilleaudeau, Patricia
Sullivan-Whalen, Mary
Suarez-Farinas, Mayte
Krueger, James G.
Guttman-Yassky, Emma
EXPERIMENTAL DERMATOLOGY, 2017, 26 (01) : 28 - 35
[7] Evaluating the safety and efficacy of baricitinib for the treatment of moderate-to-severe atopic dermatitis
Bridgeman, Sarah G.
Martino, Anna K.
Strowd, Lindsay C.
EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2153 - 2159
[8] Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis
Merola, Joseph F.
Butler, Daniel C.
Mark, Thomas
Schneider, Shannon
Kim, Yestle
Abuabara, Katrina
JAMA DERMATOLOGY, 2023, 159 (10) : 1119 - 1123
[9] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
Xu, Xinghua
Zheng, Yi
Zhang, Xin
He, Yanling
Li, Chengxin
ONCOTARGET, 2017, 8 (65) : 108480 - 108491
[10] Efficacy of abrocitinib monotherapy for the treatment of moderate-to-severe atopic dermatitis by race
Alexis, A. F.
Silverberg, J. I.
Rice, Z. P.
Armstrong, A. W.
Desai, S. R.
Fonacier, L.
Kabashima, K.
Levenberg, M.
Biswas, P.
Cella, R. Rojo
Chan, G. L.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E137 - E138

← 1 2 3 4 5 →